Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada.
Mol Pain. 2012 Jan 10;8:1. doi: 10.1186/1744-8069-8-1.
Cutaneous peripheral neuropathies have been associated with changes of the sensory fiber innervation in the dermis and epidermis. These changes are mediated in part by the increase in local expression of trophic factors. Increase in target tissue nerve growth factor has been implicated in the promotion of peptidergic afferent and sympathetic efferent sprouting following nerve injury. The primary source of nerve growth factor is cells found in the target tissue, namely the skin. Recent evidence regarding the release and extracellular maturation of nerve growth factor indicate that it is produced in its precursor form and matured in the extracellular space. It is our hypothesis that the precursor form of nerve growth factor should be detectable in those cell types producing it. To date, limitations in available immunohistochemical tools have restricted efforts in obtaining an accurate distribution of nerve growth factor in the skin of naïve animals and those with neuropathic pain lesions. It is the objective of this study to delineate the distribution of the precursor form of nerve growth factor to those cell types expressing it, as well as to describe its distribution with respect to those nerve fibers responsive to it.
We observed a decrease in peptidergic fiber innervation at 1 week after the application of a chronic constriction injury (CCI) to the sciatic nerve, followed by a recovery, correlating with TrkA protein levels. ProNGF expression in CCI animals was significantly higher than in sham-operated controls from 1-4 weeks post-CCI. ProNGF immunoreactivity was increased in mast cells at 1 week post-CCI and, at later time points, in keratinocytes. P75 expression within the dermis and epidermis was significantly higher in CCI-operated animals than in controls and these changes were localized to neuronal and non-neuronal cell populations using specific markers for each.
We describe proNGF expression by non-neuronal cells over time after nerve injury as well as the association of NGF-responsive fibers to proNGF-expressing target tissues. ProNGF expression increases following nerve injury in those cell types previously suggested to express it.
皮肤周围神经病变与真皮和表皮感觉纤维支配的变化有关。这些变化部分是由局部表达营养因子增加介导的。靶组织神经生长因子的增加被认为是促进神经损伤后肽能传入和交感传出神经发芽的原因之一。神经生长因子的主要来源是靶组织中发现的细胞,即皮肤。关于神经生长因子释放和细胞外成熟的最新证据表明,它以前体形式产生,并在细胞外空间成熟。我们的假设是,前体形式的神经生长因子应该可以在产生它的细胞类型中检测到。迄今为止,可用免疫组织化学工具的限制限制了我们在获得未受损动物和神经病理性疼痛病变动物皮肤中神经生长因子的准确分布方面的努力。本研究的目的是描述前体形式的神经生长因子在表达它的细胞类型中的分布,并描述其与对它有反应的神经纤维的分布。
我们观察到,在慢性缩窄性损伤(CCI)应用于坐骨神经后 1 周,肽能纤维支配减少,随后恢复,与 TrkA 蛋白水平相关。CCI 动物的 ProNGF 表达在 CCI 后 1-4 周显著高于假手术对照组。CCI 后 1 周,肥大细胞中 ProNGF 免疫反应性增加,而在稍后时间点,角质形成细胞中增加。CCI 手术后,真皮和表皮中的 P75 表达明显高于对照组,这些变化使用每种细胞的特定标记物定位于神经元和非神经元细胞群。
我们描述了神经损伤后一段时间内非神经元细胞中 ProNGF 的表达,以及 NGF 反应纤维与表达 ProNGF 的靶组织的关联。神经损伤后,先前被认为表达 ProNGF 的细胞类型中 ProNGF 表达增加。